Nano-Cap iBio Expands Obesity Program With New Antibody Using In-Licensed Platform
On Thursday, iBio, Inc. (NYSE:IBIO) expanded its cardiometabolic and obesity treatment development program by in-licensing a ...
조선일보6 天
Researchers leverage snake venom components to develop new hypertension treatments
Researchers leverage snake venom components to develop new hypertension treatments Innovative compounds in snake venom spark ...